Cmtm7 knockout inhibits B-1a cell development at the transitional (TrB-1a) stage

Int Immunol. 2019 Oct 16;31(11):715-728. doi: 10.1093/intimm/dxz041.

Abstract

Innate-like B-1a cells are an important cell population for production of natural IgM and interleukin-10 (IL-10), and act as the first line against pathogens. We determined that CMTM7 is essential for B-1a cell development. Following Cmtm7 (CKLF-like MARVEL transmembrane domain-containing 7) knockout, B-1a cell numbers decreased markedly in all investigated tissues. Using a bone marrow and fetal liver adoptive transfer model and conditional knockout mice, we showed that the reduction of B-1a cells resulted from B-cell-intrinsic defects. Because of B-1a cell loss, Cmtm7-deficient mice produced less IgM and IL-10, and were more susceptible to microbial sepsis. Self-renewal and homeostasis of mature B-1a cells in Cmtm7-/- mice were not impaired, suggesting the effect of Cmtm7 on B-1a cell development. Further investigations demonstrated that the function of Cmtm7 in B-1a cell development occurred at the specific transitional B-1a (TrB-1a) stage. Cmtm7 deficiency resulted in a slow proliferation and high cell death rate of TrB-1a cells. Thus, Cmtm7 controls B-1a cell development at the transitional stage.

Keywords: B-cell receptor; BCR; IgM; MARVEL; sepsis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • B-Lymphocyte Subsets / immunology
  • Cell Death
  • Cell Proliferation
  • Chemokines / deficiency
  • Chemokines / immunology*
  • MARVEL Domain-Containing Proteins / deficiency
  • MARVEL Domain-Containing Proteins / immunology*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Protein Serine-Threonine Kinases / antagonists & inhibitors*
  • Protein Serine-Threonine Kinases / immunology

Substances

  • CMTM7 protein, mouse
  • Chemokines
  • MARVEL Domain-Containing Proteins
  • Trb1 protein, mouse
  • Protein Serine-Threonine Kinases